docetaxel anhydrous has been researched along with Polyneuropathies in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersen, NT; Bennedsgaard, K; Bennett, DL; Finnerup, NB; Jensen, TS; Tankisi, H; Themistocleous, AC; Ventzel, L | 1 |
| Fiala, O; Fínek, J; Holubec, L; Matějka, VM; Mrázková, P | 1 |
| Eckhoff, L; Gaist, D; Krøigård, T; Pfeiffer, P; Qvortrup, C; Schrøder, HD; Sindrup, SH | 1 |
| Carducci, MA; Dolan, ME; Dorsey, SG; Febbo, PG; Friedman, PN; Furukawa, Y; Halabi, S; Hertz, DL; Jiang, C; Kelley, MJ; Kelly, WK; Krens, SD; Kroetz, DL; Kubo, M; Lassiter, C; Lessans, S; Mahoney, JF; McLeod, HL; Morris, MJ; Mulkey, F; Nakamura, Y; Owzar, K; Patel, J; Ratain, MJ; Renn, CL; Shterev, I; Sibley, AB; Small, EJ; Watson, D; Weisman, L; Wheeler, HE; Wing, C | 1 |
| Gedlicka, C; Kornek, GV; Scheithauer, W; Schmid, K | 1 |
2 trial(s) available for docetaxel anhydrous and Polyneuropathies
| Article | Year |
|---|---|
Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Docetaxel; Double-Blind Method; Genetic Predisposition to Disease; Genome-Wide Association Study; Genotype; Humans; Intracellular Signaling Peptides and Proteins; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Pharmacogenomic Testing; Polymorphism, Single Nucleotide; Polyneuropathies; Prednisone; Prostatic Neoplasms, Castration-Resistant; Taxoids | 2016 |
Amelioration of docetaxel/cisplatin induced polyneuropathy by alpha-lipoic acid.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Cisplatin; Docetaxel; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Paclitaxel; Polyneuropathies; Taxoids; Thioctic Acid | 2003 |
3 other study(ies) available for docetaxel anhydrous and Polyneuropathies
| Article | Year |
|---|---|
Oxaliplatin- and docetaxel-induced polyneuropathy: clinical and neurophysiological characteristics.
Topics: Aged; Antineoplastic Agents; Diagnostic Techniques, Neurological; Docetaxel; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasms; Neuralgia; Oxaliplatin; Polyneuropathies; Prospective Studies; Quality of Life; Severity of Illness Index | 2020 |
[Polyneuropathic pain therapy with a patient suffering from generalized castrate- resistant prostate cancer - clinical case report].
Topics: Aged; Analgesics; Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Resistance, Neoplasm; Humans; Male; Pain Management; Phenols; Polyneuropathies; Prostate-Specific Antigen; Prostatic Neoplasms; Tapentadol; Taxoids | 2013 |
Characterization and diagnostic evaluation of chronic polyneuropathies induced by oxaliplatin and docetaxel comparing skin biopsy to quantitative sensory testing and nerve conduction studies.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biopsy; Docetaxel; Humans; Middle Aged; Neoplasms; Neural Conduction; Organoplatinum Compounds; Oxaliplatin; Polyneuropathies; Sensation; Skin; Taxoids | 2014 |